Nonprescription diet pill alli back in stores after recall


Save Story

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

PARSIPPANY, N.J. (AP) — GlaxoSmithKline's diet pill, alli (ow-LEYE'), is now back in most U.S. stores.

The British drugmaker voluntary recalled the product last March after finding some packages in stores didn't contain real alli, indicating tampering after shipment. The Food and Drug Administration is still investigating.

Glaxo's innovation center for consumer products, in Parsippany, New Jersey, says the product package was redesigned to make tampering easier to spot.

Before shipping alli, known chemically as orlistat, to retail stores, Glaxo launched it in mid-February through Drugstore.com and other online retailers. Since late January, it's been available for preorders on Amazon.com, where Glaxo says it was the top-selling diet item during the first pre-order week.

GlaxoSmithKline says alli is the only nonpresciption diet medicine approved in the U.S. that's proven to help people lose weight.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.
    Newsletter Signup

    KSL Weather Forecast

    KSL Weather Forecast
    Play button